Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada
Abstract
In 2003-2004, there was an increase in the proportion of patients with CDAD believed, by their attending physicians, to have experienced metronidazole treatment failure, as well as an increase in the frequency of post-metronidazole therapy recurrences, especially among elderly persons.
Keywords
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
adult
adolescent
aged
middle aged
Child
Infant
Recurrence
preschool
risk factors
anti-bacterial agents / therapeutic use
metronidazole / therapeutic use
vancomycin / therapeutic use
enterocolitis
treatment failure
quebec
pmid:15889355
doi:10.1086/430315
jacques pepin
marie-eve alary
claude bourassa
pseudomembranous / drug therapy*
Access
Citation
ID:
273088
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
273088
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet